Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) shares reached a new 52-week low during trading on Wednesday . The company traded as low as $12.56 and last traded at $12.56, with a volume of 501 shares traded. The stock had previously closed at $15.5640.
Ambu A/S Stock Performance
The company has a market capitalization of $2.95 billion, a price-to-earnings ratio of 66.11 and a beta of 0.85. The company’s 50-day moving average price is $15.76 and its two-hundred day moving average price is $15.52. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.90 and a quick ratio of 1.73.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a net margin of 5.93% and a return on equity of 6.11%.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Featured Stories
- Five stocks we like better than Ambu A/S
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Stardust’s Strategic Lithium Deal Could Be a Game-Changer
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Sticker Shock: Why Kimberly-Clark’s Sell-Off Is an Overreaction
- What is a Secondary Public Offering? What Investors Need to Know
- Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
